Stocks that were in focus included names like Novartis India, which rose 15.44%, Global Health, which fell 2.9%, and YES Bank, whose shares declined 4.58% on Monday.
Capital One to Acquire Discover in $35.3 Billion Deal
“A space that is already dominated by a relatively small number of megaplayers is about to get a little smaller,” said Matt Schulz, chief credit analyst at LendingTree.
Taking Stock: Bull-run continues; Nifty hits fresh all-time high, Sensex gains 282 points
Top gainers on the Nifty were Grasim Industries, Bajaj Finserv, Bajaj Auto, ICICI Bank and Cipla, while losers were Coal India, SBI Life Insurance, LT, Wipro and HDFC LifeNifty, Sensex gain on optimism; focus on global developments, stock-specific moves
There is tremendous investor confidence among domestic investors. Even when FPIs are selling occasionally, like in October and November, domestic investors are showing confidence in the market, backed by fundamentals, said Nilesh Shah, CEO, Kotak MF.Nifty hits fresh record high; bank, auto, consumer durables lead the pack
All indices were trading in the green even as fear gauge the India VIX soared 5.14 percentAt multi-year highs: M&M among 5 stocks that witnessed 5-year swing high breakout
A 5-year swing high represents the highest price a stock has reached within a five-year timeframe.
Dollar steady as sticky inflation dents rate cut expectations
The yen has hovered around 150 level in the last few days, prompting officials to comment on the currency moves and keeping markets on alert to a possible intervention by Japanese authorities.
Oil down in thin trade as US gears up for Presidents’ Day
Brent crude futures were down 58 cents, or 0.69%, at $82.89 a barrel. U.S. West Texas Intermediate crude was 35 cents, or 0.44%, lower at $78.84 at 0138 GMT.
Gala Precision Engineering IPO: Precision component manufacturer files draft paper with SEBI
Gala Precision Engineering IPO has a fresh issue of up to 25.58 lakh shares and the OFS of up to 6.16 lakh equity shares. Up to 50% will be allocated to qualified institutional buyers (QIBs), 15% to non-institutional bidders and 35% to retail individual bidders.
Will the rally in PSU and pharma baskets continue? Ashi Anand weighs in
“The pain of very large corporate NPAs that they recognised over the last four-five years has now gone away and they are going through a period of normalisation. We are a little more comfortable with the higher-quality PSUs and I think SBI clearly stands out out there.”